These results were consistent with those obtained by flow cytometry and verified that the down-regulation of ST6Gal-I can increase the chemo-sensitivity of cervical cancer cells to cisplatin (Fig. 4). The gene discussed is ST6GAL1; the disease is cervical cancer.